Smart Ultrasound® — AI for Breast and Thyroid Cancer Diagnosis
intellimed is the exclusive distributor of Koios Medical in Switzerland. The Koios DS suite analyzes ultrasound images in seconds to classify breast and thyroid lesions—reducing unnecessary biopsies and false positives.
AI-assisted diagnosis for the classification of breast lesions on ultrasound — a 35–40% reduction in unnecessary biopsies.
Classification of injuries by seconds
Unnecessary biopsies – 35% to 40%
Reduced 6-month follow-up
Koios DS™ Thytoid
AI-Based Assessment of Thyroid Cancer Risk — Improves Diagnostic Accuracy and Reduces Unnecessary Procedures.
Analysis of 17,900 features per image
Multi-source algorithms
Integrated into the existing workflow
THE TWO KOIOS DS SOLUTIONS
Koios DS™ Breast
PROVEN CLINICAL IMPACT
-40%
unnecessary follow-up appointments
49%
shorter processing time
“Asecond lesion had very benign characteristics, but I was surprised when I ran Koios—it was a BI-RADS 4. We biopsied the lesion, and it turned out to be cancer.”
-35–40%
biopsies of benign tissue
KOIOS RESOURCES
Clinical research
Partners
Are you based in Switzerland?
Contact intellimed: your local representative for Koios DS Breast & Thyroid.
Koios DS is a CE-marked and FDA-cleared medical device. The activation data is current as of July 31, 2022.